Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-19), Shanghai INT Medical Instruments Co's Beta is 0.2403.
Shanghai INT Medical Instruments Co (HKSE:01501) Beta Explanation
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
Shanghai INT Medical Instruments Co Beta Related Terms
Shanghai INT Medical Instruments Co Beta Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai INT Medical Instruments Co Beta vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Beta distribution charts can be found below:
* The bar in red indicates where Shanghai INT Medical Instruments Co's Beta falls into.
Shanghai INT Medical Instruments Co Beta Calculation
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Shanghai INT Medical Instruments Co (HKSE:01501) has a Beta of 0.2403 as of Jul. 19, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shanghai INT Medical Instruments Co and its competitors.
Is Shanghai INT Medical Instruments Co's Beta too high?
Shanghai INT Medical Instruments Co's current Beta is 0.2403. Overall, Shanghai INT Medical Instruments Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai INT Medical Instruments Co's Beta compare to ISRG and BDX?
Shanghai INT Medical Instruments Co's Beta of 0.2403 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shanghai INT Medical Instruments Co and its competitors. Shanghai INT Medical Instruments Co's current Beta is 0.2403. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai INT Medical Instruments Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai INT Medical Instruments Co (HKSE:01501) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$39.95, compared to a current price of HK$32.90 — trading 17.6% below its estimated fair value. The current Beta is 0.2403. Shanghai INT Medical Instruments Co's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Shanghai INT Medical Instruments Co (HKSE:01501), the current Beta is 0.2403 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai INT Medical Instruments Co (HKSE:01501) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai INT Medical Instruments Co stock appears to be undervalued.
The current stock price of HK$32.90 is trading 17.6% below its estimated GF Value™ of HK$39.95.
GuruFocus considers Shanghai INT Medical Instruments Co to be Modestly Undervalued.
Key valuation signals for HKSE:01501:
Beta: 0.2403
GF Value™: HK$39.95 vs. price of HK$32.90 (17.6% below fair value)
No single metric tells the full story. See the HKSE:01501 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai INT Medical Instruments Co Business Description
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
93GF Score
Get the complete analysis for HKSE:01501
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01501 has been successfully added to your 
